Phase
Condition
N/ATreatment
Hot Cognitive Task
Structural magnetic resonance imaging (sMRI)
Magnetoencephalography imaging (MEG)
Clinical Study ID
Ages 21-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male and female participants
Age between 21-80 years old
DSM-5 diagnosis of major depressive disorder (MDD) based on Mini NeuropsychiatricInterview
Inventory of Depressive Symptomatology-Clinician Rated version (IDS-C) total score > 14
Able to read, write, and comprehend English
Provide informed consent; willing to comply with study protocol
Exclusion
Exclusion Criteria:
History of bipolar disorder, schizophrenia, or schizoaffective disorder
Presence of psychotic features
Lifetime central nervous system (CNS) disease (including head injury with loss ofconsciousness > 5 minutes)
History of neurodevelopmental disorder (e.g., Autism spectrum disorder)
History of medical conditions that can affect neurocognitive function as well as beconfounded with age (e.g., thyroid disease, endocrine illnesses)
Women who are pregnant
Current use of medications with known impacts on neurocognitive function (e.g.,acetylcholinesterase inhibitors, amphetamine, methylphenidate, vortioxetine,sedatives)
Alcohol/substance use disorder within past 3 months
DSM-5 diagnosis of major cognitive impairment
Current sensory or physical impairment that interferes with testing.
Contraindication to MRI and MEG (only for depressed participants) (e.g., anyelectronic / metallic implants near or within the head or body, claustrophobia)
Study Design
Study Description
Connect with a study center
University of Texas Arlington
Arlington, Texas 76010
United StatesSite Not Available
University of Texas Southwestern Medical Center
Dallas, Texas 75390-9127
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.